Track the OXURION share price and the full directors' dealings record of the company, a publicly traded company based in Belgium. Shares are quoted on the BE market, under the authority of FSMA. Market capitalisation: €366k. The latest transaction was disclosed on 10 March 2022 (Purchase). Among the most active insiders: Bareldam SA. All data is accessible without an account.
3
Insider Decl.
n/a
Thresholds
€3m
2 ops.
Buy Volume
n/a
n/a
Sell Volume
15Σ signal
Buys €3mn/a Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,766,337 shares@ €2.03100.0% of flowShareOff exchangeISINISIN BE0003846632FSMA:oxurion-0
3 of 3 declarations
Acerca de OXURION
OXURION es una empresa biofarmacéutica belga centrada en el desarrollo de tratamientos para enfermedades oculares. Su objetivo es proporcionar terapias innovadoras para mejorar la visión de los pacientes.